This study suggested that anti‐MDA5 Ab‐positive dermatomyositis patients had a higher incidence of RP‐ILD and a higher mortality than anti‐MDA5 Ab‐negative dermatomyositis patients. This evidence concerns the gene IFIH1 and interstitial lung disease.